EE64 ALIGNMENT OF ESTIMATED ACQUISITION COSTS IN U.S. GENE THERAPY COST EFFECTIVENESS ANALYSES WITH STANDARD PRICE BENCHMARKS
Value in Health · 2026-06 · 29 (6) · S75
DOI: 10.1016/j.jval.2026.03.359 ↗Kurz gefasst
Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Adeola S. Bakare und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Bakare, A. S., Pelc, A., Rahimian, M., Brown, L. M., Fleming, M., Shukla, V., Rodriguez-monguio, R., & Seoane-Vazquez, E. (2026). EE64 ALIGNMENT OF ESTIMATED ACQUISITION COSTS IN U.S. GENE THERAPY COST EFFECTIVENESS ANALYSES WITH STANDARD PRICE BENCHMARKS. Value in Health, 29(6), S75. https://doi.org/10.1016/j.jval.2026.03.359
Vancouver
Bakare AS, Pelc A, Rahimian M, Brown LM, Fleming M, Shukla V, et al. EE64 ALIGNMENT OF ESTIMATED ACQUISITION COSTS IN U.S. GENE THERAPY COST EFFECTIVENESS ANALYSES WITH STANDARD PRICE BENCHMARKS. Value in Health. 2026;29(6):S75. doi:10.1016/j.jval.2026.03.359
BibTeX
@article{Bakare2026,
author = {Bakare, Adeola S. and Pelc, Anna and Rahimian, Mana and Brown, Lawrence M. and Fleming, Marc and Shukla, Vaishali and Rodriguez-monguio, Rosa and Seoane-Vazquez, Enrique},
title = {EE64 ALIGNMENT OF ESTIMATED ACQUISITION COSTS IN U.S. GENE THERAPY COST EFFECTIVENESS ANALYSES WITH STANDARD PRICE BENCHMARKS},
journal = {Value in Health},
year = {2026},
volume = {29},
number = {6},
pages = {S75},
doi = {10.1016/j.jval.2026.03.359}
}
EUVIMED